New Research Study: A Behavioral Activation App for Depression During Pregnancy
We are now recruiting for a study using a novel app using behavioral activation to treat depression during pregnancy.
We are now recruiting for a study using a novel app using behavioral activation to treat depression during pregnancy.
In terms of the efficacy of bright light therapy for depression during pregnancy, the jury is still out.Â
NPR’s 1A Live hosts an episode focusing on perinatal depression, including information on the new medication zuranolone for the treatment of postpartum depression.Â
Greater attention to eating behaviors and screening eating disorders during pregnancy is the first step in improving outcomes in this population.
Exposure to interpersonal violence during both early childhood and pregnancy may pose a long-term risk for worse health outcomes.
The American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM) now recommend that all pregnant individuals be vaccinated against COVID-19.
Electroconvulsive therapy (ECT) is a safe and effective treatment for many psychiatric illnesses occurring during pregnancy.
Research has also identified an increased risk of disordered eating symptoms in the perinatal period even among women without an eating disorder diagnosis, yet gaps exist in our knowledge pertaining to the association between psychosocial risk factors and disordered eating in this population.
Infants exposed to maternal depression during pregnancy had significantly larger subcortical grey matter volumes and smaller midbrain volumes.
Neuroimaging studies indicate that exposure to antenatal depression may determine risk for later neuropsychiatric illness in the child.